Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Syros Pharmaceuticals < Previous 1 2 Next > Syros to Participate in Upcoming Investor Conferences in March February 28, 2023 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 2, 2023 February 23, 2023 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 09, 2023 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Announces Clinical Updates and 2023 Strategic Priorities January 09, 2023 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 23, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Pharmaceuticals Announces Publication in Blood Advances Demonstrating the Potential of Tamibarotene in Patients with RARA Gene Overexpression, Supporting Ongoing Clinical Development in AML and MDS December 12, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Presents Safety Lead-in Data from SELECT-AML-1 Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine and Announces Plans to Initiate Randomized Portion of Phase 2 Trial December 10, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros to Host Virtual Event to Discuss Initial SELECT-AML-1 Data and Unmet Need in Newly Diagnosed Unfit Acute Myeloid Leukemia on December 10 December 05, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros to Participate at Piper Sandler 34th Annual Healthcare Conference November 22, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update November 14, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 November 07, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 04, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Pharmaceuticals to Present Initial Data from SELECT-AML-1 Phase 2 Trial at 64th ASH Annual Meeting November 03, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 05, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros to Present at H.C. Wainwright 24th Annual Global Investment Conference September 07, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 02, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Reports Second Quarter 2022 Financial Results and Provides a Corporate Update August 09, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 04, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Tamibarotene for the Treatment of MDS August 03, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022 August 02, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement July 05, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS TYME Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 01, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros to Present at JMP Securities Life Sciences Conference June 08, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 03, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update May 16, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros to Report First Quarter 2022 Financial Results on Monday, May 16, 2022 May 09, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 29, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Presents New Preclinical Data on its CDK12 Inhibitor Program at American Association for Cancer Research (AACR) Annual Meeting 2022 April 08, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 01, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS Syros Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones March 15, 2022 From Syros Pharmaceuticals Via Business Wire Tickers SYRS < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.